Company / Free Cash Flow
Doximity Free Cash Flow History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$273.3M
FY2024
5-year range
$124.7M / $273.3M
FY2020-FY2024
Trend
+48.6%
vs FY2023
Sector context
#55 of 145
Health Care
What the data says
At $273M, Doximity's free cash flow ranks #55 of 145 in the Health Care sector. Free Cash Flow has increased for 5 consecutive years, from $26M in FY2019 to $273M in FY2024.
Based on SEC 10-K filings.
$273M in FY2024 with a 5-year CAGR of +60.2%.
Improved from $178M to $273M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +29.9%
- 5-Year CAGR
- +60.2%
- 10-Year CAGR
- -
Sector benchmark
#55 of 145 in Health CareTop 38% of 145This company $273.3M Sector average $770.9M
▼
-64.6% below sector average
Key checks
Key Insights
- Doximity's free cash flow has grown for 5 consecutive years.
- 5-year CAGR of +60.2%, indicating consistent growth.
- In FY2024, free cash flow increased 48.6% year-over-year.
- Ranks #55 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $273.3M | +48.6% |
| FY2023 | $183.9M | +3.4% |
| FY2022 | $177.9M | +42.7% |
| FY2021 | $124.7M | +50.7% |
| FY2020 | $82.7M | +219.2% |
| FY2019 | $25.9M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026